Cerus Basic EPS 2010-2025 | CERS
Cerus basic eps from 2010 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| Cerus Annual Basic EPS | |
|---|---|
| 2024 | $-0.11 |
| 2023 | $-0.21 |
| 2022 | $-0.24 |
| 2021 | $-0.32 |
| 2020 | $-0.37 |
| 2019 | $-0.51 |
| 2018 | $-0.44 |
| 2017 | $-0.56 |
| 2016 | $-0.62 |
| 2015 | $-0.58 |
| 2014 | $-0.52 |
| 2013 | $-0.64 |
| 2012 | $-0.29 |
| 2011 | $-0.35 |
| 2010 | $-0.42 |
| 2009 | $-0.69 |
| Cerus Quarterly Basic EPS | |
|---|---|
| 2025-03-31 | $-0.04 |
| 2024-12-31 | $-0.01 |
| 2024-09-30 | $-0.02 |
| 2024-06-30 | $-0.03 |
| 2024-03-31 | $-0.05 |
| 2023-12-31 | $-0.01 |
| 2023-09-30 | $-0.04 |
| 2023-06-30 | $-0.07 |
| 2023-03-31 | $-0.09 |
| 2022-12-31 | $-0.07 |
| 2022-09-30 | $-0.05 |
| 2022-06-30 | $-0.05 |
| 2022-03-31 | $-0.07 |
| 2021-12-31 | $-0.06 |
| 2021-09-30 | $-0.07 |
| 2021-06-30 | $-0.09 |
| 2021-03-31 | $-0.10 |
| 2020-12-31 | $-0.10 |
| 2020-09-30 | $-0.08 |
| 2020-06-30 | $-0.09 |
| 2020-03-31 | $-0.10 |
| 2019-12-31 | $-0.11 |
| 2019-09-30 | $-0.13 |
| 2019-06-30 | $-0.13 |
| 2019-03-31 | $-0.14 |
| 2018-12-31 | $-0.12 |
| 2018-09-30 | $-0.11 |
| 2018-06-30 | $-0.10 |
| 2018-03-31 | $-0.11 |
| 2017-12-31 | $-0.10 |
| 2017-09-30 | $-0.12 |
| 2017-06-30 | $-0.16 |
| 2017-03-31 | $-0.18 |
| 2016-12-31 | $-0.13 |
| 2016-09-30 | $-0.14 |
| 2016-06-30 | $-0.18 |
| 2016-03-31 | $-0.17 |
| 2015-12-31 | $-0.15 |
| 2015-09-30 | $-0.16 |
| 2015-06-30 | $-0.17 |
| 2015-03-31 | $-0.10 |
| 2014-12-31 | $-0.16 |
| 2014-09-30 | $-0.14 |
| 2014-06-30 | $-0.10 |
| 2014-03-31 | $-0.12 |
| 2013-12-31 | $-0.08 |
| 2013-09-30 | $-0.29 |
| 2013-06-30 | $-0.10 |
| 2013-03-31 | $-0.17 |
| 2012-12-31 | $-0.02 |
| 2012-09-30 | $-0.06 |
| 2012-06-30 | $-0.04 |
| 2012-03-31 | $-0.17 |
| 2011-12-31 | $-0.16 |
| 2011-09-30 | $0.05 |
| 2011-06-30 | $-0.13 |
| 2011-03-31 | $-0.11 |
| 2010-12-31 | $-0.05 |
| 2010-09-30 | $-0.09 |
| 2010-06-30 | $-0.14 |
| 2010-03-31 | $-0.14 |
| 2009-12-31 | $-0.11 |
| 2009-09-30 | $-0.16 |
| 2009-06-30 | $-0.19 |
| 2009-03-31 | $-0.23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.247B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.035B | 26.74 |
| Boston Scientific (BSX) | United States | $152.087B | 36.27 |
| Stryker (SYK) | United States | $143.981B | 29.31 |
| EssilorLuxottica (ESLOY) | France | $137.519B | 0.00 |
| Medtronic (MDT) | Ireland | $118.029B | 16.74 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.517B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.032B | 24.56 |
| ResMed (RMD) | United States | $41.478B | 29.66 |
| GE HealthCare Technologies (GEHC) | United States | $33.973B | 15.97 |
| Agilent Technologies (A) | United States | $33.326B | 21.73 |
| Terumo (TRUMY) | Japan | $27.583B | 32.68 |
| Koninklijke Philips (PHG) | Netherlands | $25.989B | 17.19 |
| Insulet (PODD) | United States | $21.796B | 73.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.170B | 12.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.868B | 0.00 |
| Baxter (BAX) | United States | $12.317B | 9.52 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.240B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.436B | 27.31 |
| Lantheus Holdings (LNTH) | United States | $3.665B | 9.91 |
| Envista Holdings (NVST) | United States | $3.472B | 24.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.214B | 14.26 |
| Perrigo (PRGO) | Ireland | $3.174B | 7.93 |
| ICU Medical (ICUI) | United States | $2.723B | 18.54 |
| Haemonetics (HAE) | United States | $2.516B | 11.23 |
| LeMaitre Vascular (LMAT) | United States | $2.137B | 45.82 |
| Curaleaf Holdings (CURLF) | Canada | $1.824B | 0.00 |
| AtriCure (ATRC) | United States | $1.781B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.732B | 74.36 |
| QuidelOrtho (QDEL) | United States | $1.710B | 10.77 |
| AdaptHealth (AHCO) | United States | $1.287B | 18.35 |
| Phibro Animal Health (PAHC) | United States | $1.203B | 15.38 |
| BioLife Solutions (BLFS) | United States | $1.153B | 2406.00 |
| Acuren (TIC) | United States | $1.142B | 0.00 |
| Neogen (NEOG) | United States | $1.136B | 18.03 |
| Tilray Brands (TLRY) | Canada | $1.046B | 0.00 |
| InMode (INMD) | Israel | $0.899B | 8.32 |
| Valneva SE (VALN) | France | $0.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Surmodics (SRDX) | United States | $0.542B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.511B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.465B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.439B | 15.10 |
| CeriBell (CBLL) | United States | $0.429B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 3.75 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.368B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.357B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.318B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.289B | 21.88 |
| Omeros (OMER) | United States | $0.258B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.244B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.233B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.95 |
| Quanterix (QTRX) | United States | $0.221B | 0.00 |
| Organigram Global (OGI) | Canada | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.210B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.40 |
| Biote (BTMD) | United States | $0.158B | 4.74 |
| FitLife Brands (FTLF) | United States | $0.158B | 19.40 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.09 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Veru (VERU) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.50 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.38 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |